Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Visceral Pain Treatment Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Visceral Pain Treatment Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 HS-665
      • 1.3.3 CC-8464
      • 1.3.4 BLU-5937
      • 1.3.5 APD-371
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Visceral Pain Treatment Market Share by Application (2019-2025)
      • 1.4.2 In-patient
      • 1.4.3 Out-patient
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Visceral Pain Treatment Market Size
      • 2.1.1 Global Visceral Pain Treatment Revenue 2014-2025
      • 2.1.2 Global Visceral Pain Treatment Sales 2014-2025
    • 2.2 Visceral Pain Treatment Growth Rate by Regions
      • 2.2.1 Global Visceral Pain Treatment Sales by Regions 2014-2019
      • 2.2.2 Global Visceral Pain Treatment Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Visceral Pain Treatment Sales by Manufacturers
      • 3.1.1 Visceral Pain Treatment Sales by Manufacturers 2014-2019
      • 3.1.2 Visceral Pain Treatment Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Visceral Pain Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Visceral Pain Treatment Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Visceral Pain Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.3 Visceral Pain Treatment Price by Manufacturers
    • 3.4 Key Manufacturers Visceral Pain Treatment Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Visceral Pain Treatment Market
    • 3.6 Key Manufacturers Visceral Pain Treatment Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 HS-665 Sales and Revenue (2014-2019)
      • 4.1.2 CC-8464 Sales and Revenue (2014-2019)
      • 4.1.3 BLU-5937 Sales and Revenue (2014-2019)
      • 4.1.4 APD-371 Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Visceral Pain Treatment Sales Market Share by Type
    • 4.3 Global Visceral Pain Treatment Revenue Market Share by Type
    • 4.4 Visceral Pain Treatment Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Visceral Pain Treatment Sales by Application

    6 United States

    • 6.1 United States Visceral Pain Treatment Breakdown Data by Company
    • 6.2 United States Visceral Pain Treatment Breakdown Data by Type
    • 6.3 United States Visceral Pain Treatment Breakdown Data by Application

    7 European Union

    • 7.1 European Union Visceral Pain Treatment Breakdown Data by Company
    • 7.2 European Union Visceral Pain Treatment Breakdown Data by Type
    • 7.3 European Union Visceral Pain Treatment Breakdown Data by Application

    8 China

    • 8.1 China Visceral Pain Treatment Breakdown Data by Company
    • 8.2 China Visceral Pain Treatment Breakdown Data by Type
    • 8.3 China Visceral Pain Treatment Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Visceral Pain Treatment Breakdown Data by Company
    • 9.2 Rest of World Visceral Pain Treatment Breakdown Data by Type
    • 9.3 Rest of World Visceral Pain Treatment Breakdown Data by Application
    • 9.4 Rest of World Visceral Pain Treatment Breakdown Data by Countries
      • 9.4.1 Rest of World Visceral Pain Treatment Sales by Countries
      • 9.4.2 Rest of World Visceral Pain Treatment Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Addex Therapeutics Ltd
      • 10.1.1 Addex Therapeutics Ltd Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Visceral Pain Treatment
      • 10.1.4 Visceral Pain Treatment Product Introduction
      • 10.1.5 Addex Therapeutics Ltd Recent Development
    • 10.2 Astellas Pharma Inc.
      • 10.2.1 Astellas Pharma Inc. Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Visceral Pain Treatment
      • 10.2.4 Visceral Pain Treatment Product Introduction
      • 10.2.5 Astellas Pharma Inc. Recent Development
    • 10.3 Chromocell Corporation
      • 10.3.1 Chromocell Corporation Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Visceral Pain Treatment
      • 10.3.4 Visceral Pain Treatment Product Introduction
      • 10.3.5 Chromocell Corporation Recent Development
    • 10.4 GIcare Pharma Inc
      • 10.4.1 GIcare Pharma Inc Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Visceral Pain Treatment
      • 10.4.4 Visceral Pain Treatment Product Introduction
      • 10.4.5 GIcare Pharma Inc Recent Development
    • 10.5 Grunenthal GmbH
      • 10.5.1 Grunenthal GmbH Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Visceral Pain Treatment
      • 10.5.4 Visceral Pain Treatment Product Introduction
      • 10.5.5 Grunenthal GmbH Recent Development
    • 10.6 Medestea Research & Production S.p.A.
      • 10.6.1 Medestea Research & Production S.p.A. Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Visceral Pain Treatment
      • 10.6.4 Visceral Pain Treatment Product Introduction
      • 10.6.5 Medestea Research & Production S.p.A. Recent Development
    • 10.7 Neurim Pharmaceuticals Ltd
      • 10.7.1 Neurim Pharmaceuticals Ltd Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Visceral Pain Treatment
      • 10.7.4 Visceral Pain Treatment Product Introduction
      • 10.7.5 Neurim Pharmaceuticals Ltd Recent Development
    • 10.8 Pfizer Inc.
      • 10.8.1 Pfizer Inc. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Visceral Pain Treatment
      • 10.8.4 Visceral Pain Treatment Product Introduction
      • 10.8.5 Pfizer Inc. Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Visceral Pain Treatment Sales Channels
      • 11.2.2 Visceral Pain Treatment Distributors
    • 11.3 Visceral Pain Treatment Customers

    12 Market Forecast

    • 12.1 Global Visceral Pain Treatment Sales and Revenue Forecast 2019-2025
    • 12.2 Global Visceral Pain Treatment Sales Forecast by Type
    • 12.3 Global Visceral Pain Treatment Sales Forecast by Application
    • 12.4 Visceral Pain Treatment Forecast by Regions
      • 12.4.1 Global Visceral Pain Treatment Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Visceral Pain Treatment Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In 2019, the market size of Visceral Pain Treatment is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Visceral Pain Treatment.

      This report studies the global market size of Visceral Pain Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Visceral Pain Treatment sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Addex Therapeutics Ltd
      Astellas Pharma Inc.
      Chromocell Corporation
      GIcare Pharma Inc
      Grunenthal GmbH
      Medestea Research & Production S.p.A.
      Neurim Pharmaceuticals Ltd
      Pfizer Inc.

      Market Segment by Product Type
      HS-665
      CC-8464
      BLU-5937
      APD-371
      Others

      Market Segment by Application
      In-patient
      Out-patient

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Visceral Pain Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Visceral Pain Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Visceral Pain Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now